Health
Whole-Genome Sequencing Is Accurate for Myeloid Cancers – HealthDay News
Prospective sequencing of samples provided new genetic information for 24.8 percent of patients, which changed risk category for 16.2 percent
WEDNESDAY, March 10, 2021 (HealthDay News) — A streamlined whole-genome sequencing approach can provide rapid and accurate genomic profiling for acute myeloid leukemia (AML) or myelodysplastic syndromes, according to a study published in the March 11 issue of the New England Journal of Medicine.
Eric J. Duncavage, M.D., from the Washington University School of Medicine in St. Louis, and colleagues used a streamlined whole-genome sequencing approach to obtain genomic profiles for 263 patients with…
-
Noosa News15 hours agoPill checking to resume in Queensland months after government axed funding
-
Business18 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Noosa News23 hours agoThe Full Trailer for Yorgos Lanthimos’ Emma Stone-Led CEO-Kidnapping Dark Comedy ‘Bugonia’ Is Here
-
Business17 hours agoWhy Lynas, Mesoblast, PEXA, and Sayona Mining shares are tumbling today